General Surgery Devices Market by Type, Application, End-use

Description

List of Tables

[198 Pages Report] The General Surgery Devices Market size was estimated at USD 17.84 billion in 2023 and expected to reach USD 18.94 billion in 2024, at a CAGR 6.67% to reach USD 28.04 billion by 2030.

General surgery devices refer to a range of instruments and tools specifically designed to assist with operations and procedures commonly performed during general surgery. These devices can include a variety of tools such as scalpels, forceps, scissors, and sutures. Additionally, more advanced equipment, including electrosurgical devices, which use electrical energy to cut or control bleeding, and staple devices, which are used to close wounds or incisions, are considered part of this category. The growth in the prevalence of chronic diseases that require surgical intervention, coupled with a growing aging population, is primarily pushing the market forward. Additionally, improvements and expansions in healthcare infrastructure in developing countries present opportunities for the adoption of advanced surgical devices. However, the high cost of advanced surgical devices can be a significant hindrance, particularly in less developed regions. Stringent regulations governing the approval of medical devices can delay product launches and increase development costs. Furthermore, growing demand for devices that make surgeries less invasive, reduce recovery time, and minimize complications. The development of smart surgical devices that use artificial intelligence and the Internet of Things to offer enhanced precision and efficiency in surgeries poses significant opportunities to the market.

KEY MARKET STATISTICS
Base Year [2023]	USD 17.84 billion
Estimated Year [2024]	USD 18.94 billion
Forecast Year [2030]	USD 28.04 billion
CAGR (%)	6.67%

Regional Insights

In the American region, the adoption of general surgery devices is robust due to advanced healthcare infrastructure, high healthcare expenditure, and a constant push for technological innovations. A notable trend towards minimally invasive surgeries demands precise and sophisticated surgical instruments and devices. The U.S. Food and Drug Administration (FDA) plays a crucial role in regulating and approving new devices, ensuring safety and efficacy. Canada shares these trends, with both governments actively investing in healthcare technology research. European countries benefit from well-established healthcare systems and uniform regulations enforced by the European Medicines Agency (EMA). The demand in Europe is driven by an aging population and a high standard of surgical care. In the Middle East region, the Gulf states have modern medical facilities and are investing heavily in medical tourism, whereas many African countries are in urgent need of basic surgical and medical infrastructure. The APAC region is marked by rapid economic growth, increasing healthcare expenditure, and growing public health awareness. China and India, with their burgeoning middle classes and reforms in healthcare policies, show significant market potential for general surgery devices. Japan, known for its technological prowess, leads in high-end device manufacturing and innovative surgical techniques.

Market Insights

Market Dynamics

The market dynamics represent an ever-changing landscape of the General Surgery Devices Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

Market Drivers
- Increasing prevalence of chronic diseases requiring surgical intervention
- Improvements and expansions in healthcare infrastructure in developing countries
- Growing need for less invasive surgical procedures devices

Market Restraints
- High cost associated with the advanced surgical devices

Market Opportunities
- Smart surgical devices that use artificial intelligence and the Internet of Things
- Continuing to advance surgical robotics with high precision and control

Market Challenges
- Stringent regulations governing the approval of medical devices

Market Segmentation Analysis
- Type: Ongoing advancements in energy-based & powered instrument to improve precision and reduced blood loss during procedures
- End-use: Hospitals prefer surgical devices with versatility and advanced technology

Market Disruption Analysis
Porter's Five Forces Analysis
Value Chain & Critical Path Analysis
Pricing Analysis
Technology Analysis
Patent Analysis
Trade Analysis
Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the General Surgery Devices Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the General Surgery Devices Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

FDA Approval Granted to Virtual Incision's MIRA: The First Miniaturized Robotic-Assisted Surgery System for Colectomies

The U.S. Food and Drug Administration (FDA) authorized the MIRA Surgical System, developed by Virtual Incision. This milestone marks MIRA as the first miniaturized, robotic-assisted surgery (RAS) device specifically approved for use in adult colectomy procedures. MIRA's small, self-contained design enables operation directly within the abdominal cavity without requiring a dedicated operating room or creating extensive setup times. [Published On: 2024-02-24]

RTI Surgical Expands Portfolio with Strategic Acquisition of Cook Biotech

RTI Surgical has officially announced its acquisition of Cook Biotech, a division of Cook Group specializing in biologic grafts. This strategic move aims to enhance RTI Surgical's product offerings and fortify its position in the global surgical devices market. Cook Biotech is renowned for its innovative technologies in regenerative medicine, and its integration under RTI Surgical's umbrella is expected to extend RTI's capabilities in biologic grafts and broaden its influence and reach in the healthcare sector. [Published On: 2024-01-08]

Johnson & Johnson MedTech Announces Launch Schedule for Innovative General Surgery Robot

Johnson & Johnson MedTech has outlined significant details and a launch timeline for its new general surgery robot, marking a pivotal step in advancing surgical technologies. This innovative robotic system is designed to enhance precision in various surgical procedures, thereby potentially improving patient outcomes. [Published On: 2023-11-07]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the General Surgery Devices Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the General Surgery Devices Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Abbott Laboratories, B. Braun Melsungen AG, Becton, Dickinson, and Company, Cardinal Health, Inc., Carl Zeiss Meditec AG, CooperSurgical, Inc., Delta Med S.p.A., Ecolab Inc., Globus Medical, Inc., Henry Schein, Inc., Innomed, Inc., Johnson & Johnson Services Inc, Koninklijke Philips N.V., Medica Europe B.V., Medtronic PLC, Olympus Corporation, Schott AG, Siemens Healthcare GmbH, Smith & Nephew PLC, Stryker Corporation, Teleflex Incorporated, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the General Surgery Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

Type
- Adhesion Prevention Products
- Disposable Surgical Supplies
  - Examination & Surgical Gloves
  - General Surgery Procedural Kits
  - Needles and Syringes
  - Surgical Non-woven
    - Disposable Surgical Masks
    - Surgical Caps
    - Surgical Drapes
    - Surgical Gowns

Venous Access Catheters

Energy-based & Powered Instrument
- Drill System
- Powered Staplers

Medical Robotics & Computer-Assisted Surgery Devices
Minimally Invasive Surgery Instruments
- Laparoscope
- Organ Retractor

Open Surgery Instrument
- Catheters
- Dilator
- Retractor

Application
- Audiology
- Cardiology
- Neurosurgery
- Ophthalmology
- Orthopedic Surgery
- Plastic Surgery
- Thoracic Surgery
- Urology & Gynecology Surgery
- Wound Care

End-use
- Ambulatory Surgical Centers
- Hospitals
- Specialty Clinics

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam

Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom

Product Code: MRR-99555D55052D

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Increasing prevalence of chronic diseases requiring surgical intervention
  - 5.1.1.2. Improvements and expansions in healthcare infrastructure in developing countries
  - 5.1.1.3. Growing need for less invasive surgical procedures devices
- 5.1.2. Restraints
  - 5.1.2.1. High cost associated with the advanced surgical devices
- 5.1.3. Opportunities
  - 5.1.3.1. Smart surgical devices that use artificial intelligence and the Internet of Things
  - 5.1.3.2. Continuing to advance surgical robotics with high precision and control
- 5.1.4. Challenges
  - 5.1.4.1. Stringent regulations governing the approval of medical devices
5.2. Market Segmentation Analysis
- 5.2.1. Type: Ongoing advancements in energy-based & powered instrument to improve precision and reduced blood loss during procedures
- 5.2.2. End-use: Hospitals prefer surgical devices with versatility and advanced technology
5.3. Market Disruption Analysis
5.4. Porter's Five Forces Analysis
- 5.4.1. Threat of New Entrants
- 5.4.2. Threat of Substitutes
- 5.4.3. Bargaining Power of Customers
- 5.4.4. Bargaining Power of Suppliers
- 5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis

6. General Surgery Devices Market, by Type

6.1. Introduction
6.2. Adhesion Prevention Products
6.3. Disposable Surgical Supplies
6.4. Energy-based & Powered Instrument
6.5. Medical Robotics & Computer-Assisted Surgery Devices
6.6. Minimally Invasive Surgery Instruments
6.7. Open Surgery Instrument

7. General Surgery Devices Market, by Application

7.1. Introduction
7.2. Audiology
7.3. Cardiology
7.4. Neurosurgery
7.5. Ophthalmology
7.6. Orthopedic Surgery
7.7. Plastic Surgery
7.8. Thoracic Surgery
7.9. Urology & Gynecology Surgery
7.10. Wound Care

8. General Surgery Devices Market, by End-use

8.1. Introduction
8.2. Ambulatory Surgical Centers
8.3. Hospitals
8.4. Specialty Clinics

9. Americas General Surgery Devices Market

9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific General Surgery Devices Market

10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa General Surgery Devices Market

11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape

12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
- 12.3.1. FDA Approval Granted to Virtual Incision's MIRA: The First Miniaturized Robotic-Assisted Surgery System for Colectomies
- 12.3.2. RTI Surgical Expands Portfolio with Strategic Acquisition of Cook Biotech
- 12.3.3. Johnson & Johnson MedTech Announces Launch Schedule for Innovative General Surgery Robot
12.4. Strategy Analysis & Recommendation

13. Competitive Portfolio

13.1. Key Company Profiles
13.2. Key Product Portfolio